Bristol-Myers Squibb CompanyBMYNYSE
Loading
ROE: Strong ReturnsExpanding
Percentile Rank100
3Y CAGR+23.3%
Year-over-Year Change
Return on equity
3Y CAGR
+23.3%/yr
vs -12.7%/yr prior
Acceleration
+36.0pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 38.18% | +169.7% |
| 2024 | -54.78% | -300.9% |
| 2023 | 27.27% | +33.9% |
| 2022 | 20.37% | +4.7% |
| 2021 | 19.46% | +181.8% |
| 2020 | -23.78% | -456.8% |
| 2019 | 6.66% | -81.0% |
| 2018 | 35.07% | +308.8% |
| 2017 | 8.58% | -68.9% |
| 2016 | 27.55% | - |